4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-039086
CBO & COO sold 70,000 shares at an average $75.88 ($5,311,564)
- CBO & COO acquired 70,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Option exercise | +38,666 | $5.86 | $226,583 | 58,666 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −15,966 | $75.93 | $1,212,265 | 42,700 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −22,700 | $76.50 | $1,736,575 | 20,000 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Option exercise | +26,422 | $12.57 | $332,125 | 46,422 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −6,600 | $74.90 | $494,323 | 39,822 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −3,934 | $75.94 | $298,736 | 35,888 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −800 | $76.50 | $61,201 | 35,088 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −12,175 | $75.32 | $917,054 | 22,913 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Sale | −2,913 | $76.26 | $222,138 | 20,000 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-25 | Option exercise | +4,912 | $12.57 | $61,744 | 24,912 | D |
| Klein Lawrence Otto CBO & COO | 2020-06-25 | Sale | −4,912 | $75.18 | $369,272 | 20,000 | D |
| Derivatives | |||||||
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Option exercise · Stock Option (Right to Buy) | −38,666 | 0 | D | ||
| Klein Lawrence Otto CBO & COO | 2020-06-24 | Option exercise · Stock Option (Right to Buy) | −26,422 | 13,578 | D | ||
| Klein Lawrence Otto CBO & COO | 2020-06-25 | Option exercise · Stock Option (Right to Buy) | −4,912 | 8,666 | D | ||
| Open-market sales · 70,000 sh · avg $75.88 · $5,311,564 | |||||||
Loading xslF345X03/doc4.xml…